MRSA/MSSA Screening Test

Download this product sheet

The MicroPhage MRSA/MSSA screening test identifies S. aureus and differentiates methicillin-resistant S. aureus (MRSA) from methicillin-susceptible S. aureus (MSSA) colonized patients, providing the right choice when you need rapid, comprehensive results. Active surveillance can help significantly reduce S. aureus infections in a way MRSA screening alone has failed to do. With the MicroPhage MRSA/MSSA screening test, hospitals and other institutions will now be able to quickly and affordably screen patients and proactively decolonize or prophylax appropriately and more effectively. MicroPhage's bacteriophage amplification technology will provide the performance of molecular results at a price that is more in line with chromagenic culture media. The easy-to-use platform allows for simple, unbatched test starts and rapid batched or unbatched results, perfect for an early morning delivery of hospital-wide results when Infection Control can best use them. The MicroPhage MRSA/MSSA screening test is ideal for institutions concerned with screening for all S. aureus in their patients that may not have the capacity for molecular or traditional microbiology.

• Affordably screen patients – molecular performance at less than half the cost.
• Receive appropriate time to results – Get all of the previous day’s results first thing the next morning for infection control and bed management.
• Cover multiple body sites – Capture more colonized patients and better define cleared patients.
• Conduct full-coverage testing – Identify all S. aureus carriers, and distinguish MSSA and MRSA colonization for appropriate management.
• Easily implement screening programs – Visually interpret results in unbatched starts without investing in molecular tests or waiting on traditional microbiology.
• Reduce hospital-acquired infections (HAIs) – Enable proactive and effective decolonization, prophylaxis, and/or isolation.

High-value diagnostic, easy-to-use platform
The MicroPhage MRSA/MSSA Screening Test delivers rapid results that enable cost-effective patient screening and infection control. The test itself is simple to perform and does not require expensive equipment, making this critical diagnostic available to all institutions – large and small.

• Three minutes of hands-on time
• Unbatched test format
• Visual interpretation
• All results available the next morning
• Pricing that is in line with chromogenic culture media
• Specificity in the high 90s
• Sensitivity in the mid 90s